Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells

Frontiers in Oncology
Yi-Dong LiZhe-Sheng Chen

Abstract

In this study, we investigated the efficacy of methyl-cantharidimide (MCA), a cantharidin (CTD) analog, as an anticancer drug, in cancer cells overexpressing either ABCB1 or ABCG2 transporters and in cisplatin-resistant cancer cells. The results indicated that: (i) MCA was efficacious in the ABCB1-overexpressing cell line, KB-C2, and the ABCB1-gene-transfected cell line, HEK293/ABCB1 (IC50 from 6.37 to 8.44 mM); (ii) MCA was also efficacious in the ABCG2-overexpressing cell line, NCI-H460/MX20, and the ABCG2-gene-transfected cell lines, HEK293/ABCG2-482-R2, HEK293/ABCG2-482-G2, and the HEK293/ABCG2-482-T7 cell lines (IC50 from 6.37 to 9.70 mM); (iii) MCA was efficacious in the cisplatin resistant cancer cell lines, KCP-4 and BEL-7404/CP20 (IC50 values from 7.05 to 8.16 mM); (iv) MCA (up to 16 mM) induced apoptosis in both BEL-7404 and BEL-7404/CP20 cancer cells; (v) MCA arrested both BEL-7404 and BEL-7404/CP20 cancer cells in the G0/G1 phase of the cell cycle; (vi) MCA (8 mM) upregulated the expression level of the protein, unc-5 netrin receptor B (UNC5B) in HepG2 and BEL-7404 cancer cells. Overall, our results indicated that MCA's efficacy in ABCB1- and ABCG2-overexpressing and cisplatin resistant cancer cells is due to the in...Continue Reading

References

Dec 1, 1988·British Journal of Cancer·S B Kaye
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·M L AgarwalG R Stark
Apr 1, 1994·Japanese Journal of Cancer Research : Gann·R FujiiS Akiyama
Apr 24, 1997·Nature·E D LeonardoM Tessier-Lavigne
Dec 15, 2000·Cell·K H Vousden
Jun 2, 2001·The EMBO Journal·F LlambiP Mehlen
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Dec 11, 2002·Biochemical Pharmacology·Seung-Whan KimDong-Kwon Rhee
Feb 25, 2003·Nature Cell Biology·Chizu TanikawaHirofumi Arakawa
Jun 11, 2004·Annual Review of Biochemistry·Aziz SancarStuart Linn
Jul 17, 2004·Chemical & Pharmaceutical Bulletin·Takafumi NakataniNaoki Noda
Aug 17, 2005·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Y A Luqmani
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Aug 29, 2006·Pflügers Archiv : European journal of physiology·Kenneth J Linton, Christopher F Higgins
Apr 11, 2007·Physiology·Kenneth J Linton
Feb 7, 2008·British Journal of Cancer·C LemosG J Peters
Jul 9, 2008·Biochemistry. Biokhimii︠a︡·A A Stavrovskaya, T P Stromskaya
Aug 30, 2008·Molecular Cancer Research : MCR·Xing-Jie LiangMichael M Gottesman
May 16, 2009·Anti-cancer Agents in Medicinal Chemistry·Dongwu Liu, Zhiwei Chen
Jul 9, 2009·Chemical Reviews·Paul D W Eckford, Frances J Sharom
Aug 10, 2010·European Journal of Medicinal Chemistry·Chao-Bin YehMing-Chih Chou
Mar 14, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Brian C ShafferMichael M Gottesman
Aug 9, 2012·Antioxidants & Redox Signaling·Balachandran S VinodRuby John Anto
Oct 16, 2012·International Journal of Environmental Research and Public Health·Ida CasorelliMargherita Bignami
Oct 22, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yi-Shiuan LiuShu-Jen Chen
Sep 11, 2014·Journal of Cancer Research and Therapeutics·Hejun ShaoXinhua Luo
Mar 12, 2015·Critical Reviews in Biotechnology·Melis Kartal-YandimYusuf Baran
Apr 1, 2014·Acta Pharmaceutica Sinica. B·Chung-Pu Wu, Suresh V Ambudkar
Dec 18, 2015·Biochimica Et Biophysica Acta·Yang Zhang, Michael R Maurizi

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis